ABATACEPT CONFERS CLINICAL EFFICACY REGARDLESS OF BASELINE CRP STATUS IN PATIENTS WITH RHEUMATOID ARTHRITIS AND INADEQUATE RESPONSE TO METHOTREXATE IN THE AIM TRIAL

被引：0
|
作者：
Sibilia, Jean [1 ]
Flipo, Rene Marc [2 ]
Combe, Bernard [3 ]
Gaillez, Corine [4 ]
Le Bars, Manuela [4 ]
Poncet, Coralie [5 ]
Elegbe, Ayanbola [6 ]
Westhovens, Rene [7 ]
机构：
[1] Univ Strasbourg, Dept Rheumatol, Strasbourg, France
[2] Ctr Hosp Univ France, Dept Rheumatol, Lille, France
[3] Hop Lapeyronie, Montpellier, France
[4] Bristol Myers Squibb Co, Med Affairs, Rueil Malmaison, France
[5] Docs Int, Dept Biostat, Sevres, France
[6] Bristol Myers Squibb Co, Global Biometr Sci, Princeton, NJ USA
[7] Univ Hosp Gasthuisberg, Dept Rheumatol, Louvain, Belgium
来源：
RHEUMATOLOGY | 2012年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：124 / 125
页数：2
相关论文
共 50 条
  • [1] Abatacept plus MTX Treatment Confers Similar Clinical Efficacy Regardless of Baseline Rheumatoid Factor or CRP Status in the AIM Trial
    Russell, Anthony
    Sibilia, Jean
    Cantagrel, Alain
    Westhovens, Rene
    Gaillez, Corine
    Le Bars, Manuela
    Poncet, Coralie
    Elegbe, Ayanbola
    Kremer, Joel
    JOURNAL OF RHEUMATOLOGY, 2012, 39 (08) : 1714 - 1715
  • [2] Safety and efficacy of abatacept over 4 years of treatment in patients with rheumatoid arthritis and an inadequate response to methotrexate in the AIM trial
    Kremer, J. M.
    Russell, A. S.
    Emery, P.
    Abud-Mendoza, C.
    Szechinski, J.
    Zhao, C.
    Becker, J-C
    Westhovens, R.
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S308 - S309
  • [3] Safety and Efficacy of Abatacept Over 4 Years of Treatment in Patients with Rheumatoid Arthritis and an Inadequate Response to Methotrexate in the AIM Trial
    Russell, A. S.
    Kremer, J. M.
    Emery, P.
    Abud-Mendoza, C.
    Szechinski, J.
    Zhao, C.
    Becker, J-C
    Westhovens, R.
    JOURNAL OF RHEUMATOLOGY, 2009, 36 (11) : 2608 - 2609
  • [4] The efficacy and safety of abatacept or infliximab in patients with rheumatoid arthritis and an inadequate response to methotrexate
    Dougados, M.
    Keiserman, M.
    Codding, C.
    Songcharoen, S.
    Berman, A.
    Nayiager, S.
    Saldate, C.
    Becker, J. C.
    Li, T.
    Schiff, M.
    RHEUMATOLOGY, 2008, 47 : II14 - II15
  • [5] Time to treatment response with abatacept in patients with rheumatoid arthritis and an inadequate response to methotrexate
    Kremer, J. M.
    Westhovens, R.
    Le Bars, M.
    Lafosse, C.
    Gaillez, C.
    Koncz, T.
    Schmidely, N.
    Dougados, M.
    Schiff, M.
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S308 - S308
  • [6] Decreased external home help use with improved clinical status in rheumatoid arthritis: An exploratory analysis of the abatacept in inadequate responders to methotrexate (AIM) trial
    Li, Tracy
    Gignac, Monique
    Wells, George
    Shen, Sophie
    Westhovens, Rene
    CLINICAL THERAPEUTICS, 2008, 30 (04) : 734 - 748
  • [7] Non-progression of structural damage over 2 years with abatacept in rheumatoid arthritis patients with an inadequate response to methotrexate in the AIM trial.
    Genant, H. K.
    Peterfy, C.
    Westhovens, R.
    Vratsanos, G.
    Becker, J-C
    Aranda, R.
    Teng, J.
    Kremer, J.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S408 - S409
  • [8] Low disease activity in rheumatoid arthritis (RA) paitents treated with Abatacept in the aim (Abatacept in inadequate responders to methotrexate [MTX]) trial
    Dougados, M.
    Le Bars, M. A.
    Schmidely, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 188 - 188
  • [9] CLINICAL EFFICACY OF ABATACEPT AND INFLIXIMAB IN COMBINATION WITH METHOTREXATE ACCORDING TO BASELINE RHEUMATOID FACTOR STATUS IN THE ATTEST TRIAL
    Dougados, Maxime
    Gaillez, Corine
    Le Bars, Manuela
    Poncet, Coralie
    Elegbe, Ayanbola
    Schiff, Michael
    RHEUMATOLOGY, 2012, 51 : 127 - 127
  • [10] The Relationship Between Power Doppler Ultrasonography Outcomes and Clinical Efficacy in Abatacept-Treated Patients with Rheumatoid Arthritis and in Inadequate Response to Methotrexate
    D'Agostino, M. A.
    Wakefield, R.
    Hammer, H. Berner
    Vittecoq, O.
    Galeazzi, M.
    Balint, P.
    Filippucci, E.
    Moller, I.
    Iagnocco, A.
    Naredo, E.
    Ostergaard, Mikkel
    Gaillez, C.
    Van Holder, K.
    Le Bars, M.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S353 - S353
12345